Article Details

Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners

Retrieved on: 2020-12-11 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners. View article details on hiswai:

Excerpt

... General Atlantic, <b>Sequoia Capital</b> China, Boyu Capital, life sciences-focused TF Capital, and Zoo Capital, SciNeuro announced on December 9.

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo